New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function

    NEXT STORY
    Mateon Therapeutics to Present New and Updated Data for OT101 (Trabedersen) Activity Against Brain Tumors at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
    PREV STORY
    Air Methods to Refund Medicare Patients as Part of ‘No Membership Required’ Program
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Terveystalo Plc: The Finnish Competition and Consumer Authority applies for an extension for investigating the transaction between Terveystalo and Attendo

    Terveystalo Plc Stock Exchange release 5 October 2018 at 09:00 a.m EEST Terveystalo Plc ...

    author_avatar
    NASDAQ Market News

    Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study

    CRANBURY, N.J., May 19, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics, Inc. (Nasdaq:FOLD),  has completed ...

    author_avatar
    NASDAQ Market News

    Tyme Technologies to Present New Clinical Data for Investigational Drug Candidate SM-88 at 2017 ASCO Annual Meeting

    NEW YORK, May 22, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical ...

    author_avatar
    NASDAQ Market News